Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
Masashi AndoKazunori HondaWaki HosodaYuki MatsubaraRyosuke KumanishiTaiko NakazawaTakatsugu OgataAkinobu NakataHiroyuki KodamaToshiki MasuishiYukiya NaritaHiroya TaniguchiShigenori KadowakiKei MuroPublished in: International journal of clinical oncology (2023)
The outcome of patients with unfavorable-risk CUP remains to be poor. Site-specific therapy based on IHC is not recommended for all patients with unfavorable-risk CUP.